Orgenesis Inc.
ORGS · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | 41.1% | 74.5% | 101% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -68.6% | -304.5% | -437.6% | 123.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,208.4% | -3,258.5% | -6,245.4% | 321.7% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 2,628.2% | -3,619.5% | -6,925.5% | 252.9% |
| EPS Diluted | -0.19 | -0.23 | -0.29 | -2.09 |
| % Growth | 17.4% | 20.7% | 86.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |